Appetite Loss in Geriatric Pets: Diagnose First, Then Reach for Drugs

Capromorelin raised food consumption by roughly 60 percent over baseline in healthy beagles, while placebo-group dogs ate less — and that FDA-approved ghrelin-receptor agonist is one of several pharmacologic options now available for geriatric inappetence. Yet the evidence-based workup for a senior dog or cat refusing food does not start with a drug. It starts with ruling out pain, nausea, dental disease and GI ulceration, because a cat with untreated degenerative joint disease will not respond reliably to pharmacologic appetite support until the discomfort itself is managed.

That framing comes from Tyler Carmack, DVM, CVA, CHPV, director of Hospice and Palliative Care for the Caring Pathways family of practices, writing for Veterinary Practice News. Her core argument: inappetence in geriatric and palliative patients is a symptom — of pain, nausea, or physical and emotional distress — that deserves the same diagnostic attention as any other clinical finding.

What drives the refusal to eat?

Appetite rests on hypothalamic signaling, gastrointestinal comfort and disease-related biochemistry working together. In cancer patients, inflammatory cytokines such as IL-1 and IL-6, plus emerging mediators like GDF-15 and activin A, act centrally to suppress hunger while accelerating muscle catabolism. Calorie supplementation alone cannot reverse that process. Uremic toxins in chronic kidney disease cause nausea; osteoarthritis makes the walk to the bowl unappealing.

Which drugs carry evidence?

• Mirtazapine antagonizes serotonergic 5-HT2A/2C and 5-HT3 receptors plus presynaptic alpha-2 receptors. Placebo-controlled crossover trials in cats with CKD showed improved appetite, weight gain and reduced vomiting with both compounded transdermal and oral formulations, and an FDA-approved transdermal product is now labeled for weight loss associated with feline CKD. In dogs, treated animals were significantly more likely to resume voluntary eating and lost less weight than untreated controls.
• Capromorelin is the first FDA-approved appetite stimulant for dogs, later approved for cats as Elura (October 2020) for managing weight loss in cats with CKD.
• Maropitant, the first FDA-approved veterinary antiemetic, targets the emetic center via NK-1 antagonism. Cats with CKD given the drug showed reduced vomiting without a corresponding rise in appetite in some studies, making it an adjunct rather than a substitute for a dedicated anti-nausea agent.
• Ondansetron, a 5-HT3 antagonist, may work better when nausea rather than active vomiting suppresses appetite. A 2022 pharmacokinetic study documented measurable anti-nausea effects with intravenous ondansetron in hospitalized dogs. Oral bioavailability in dogs is poor and variable, so inject it. Use is off-label; no ondansetron formulation is FDA-approved for veterinary patients.

Analgesics — NSAIDs guided by updated 2024 ISFM/AAFP feline consensus recommendations, gabapentin or opioids — are frequently the highest-yield intervention, since unmanaged pain suppresses appetite more reliably than almost any other single factor.

Do supplements and acupressure work?

Omega-3 fatty acids (EPA/DHA) may preserve lean muscle in cancer patients, though veterinary oncology evidence is still evolving. Warming calorically dense renal or recovery diets boosts aroma for patients with a diminished sense of smell. Probiotics carry a randomized, placebo-controlled trial in shelter cats and dogs showing reduced diarrhea episodes, supporting gut comfort rather than appetite directly. Commercial lickable toppers lack independent efficacy data and should be presented to clients accordingly.

Acupressure has one strong trial behind it. In a randomized clinical trial of 222 dogs, electroacupuncture at Pericardium 6 (PC-6), on the palmar forelimb proximal to the carpus, reduced morphine-induced nausea and vomiting as effectively as maropitant or acepromazine, and significantly better than a sham acupoint or saline. The benefit is trigger-specific: PC-6 and ST-36 acupuncture failed to reduce nausea in dogs on intravenous lidocaine infusions, and PC-6 aquapuncture did not reduce dexmedetomidine-induced vomiting in cats. Gentle digital pressure at any of these points for 20-30 seconds, repeated a few times daily, is reasonable to teach clients.

What changes at home and in the exam room?

Studies estimate 20 to 92 percent of older cats show radiographic or clinical signs of degenerative joint disease. Feline life-stage guidelines recommend raised food and water dishes, feeding stations away from stairs, and low-sided litter boxes on every level. For senior dogs, elevated bowls help those with cervical arthritis, megaesophagus or thoracic limb pain; a non-slip mat under a floor-level bowl is a safe default for most large-breed seniors.

Carmack also advises counseling owners of healthy puppies and kittens to introduce varied food textures, temperatures and forms early — a cat that has eaten one kibble flavor for 12 years is a much harder patient to support through inappetence. Consensus hospice guidelines frame the goal as comfort and voluntary intake within the caregiver-patient "unit of care," not a caloric target, and practices that build that foundation years before illness narrows a patient's options will manage these cases with far more tools.